Enrolling Now!

Study Details

This is a research study for a drug approved by the U.S Food and Drug Administration (FDA) for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. This study drug is also being developed for the potential treatment of autoimmune diseases, conditions in which the immune system mistakenly attacks the body. 

Madison, WI is currently recruiting Healthy Adults, ages 18-65. 

Refer a friend & receive $350 per qualified referral

Women Eligibility Criteria

• Women can be of childbearing potential or non-childbearing potential.

Smoking Criteria

• Smoking is allowed. 

Body Mass Index

• Participants must have a BMI of:
  • 18-34

Screening procedures

• Screening procedures for this study may include:
  • Vitals
  • Physical examination
  • Electrocardiogram (ECG)
  • Collection of blood samples
  • Drug and Alcohol testing  

Additional Details

C4

Check-in: April 29

Check-out: April 30

Follow-up visits: 

• May 2,4, 7, 10, 14, 21, 28
• June 11 & 25 
• July 9

Phone calls: 

• June 4, 18
• July 2